Michael Roth - Bonesupport Holding GM America
| BONEX Stock | SEK 371.80 3.00 0.81% |
Insider
Michael Roth is GM America of Bonesupport Holding AB
| Age | 60 |
| Phone | 46 4 62 86 53 70 |
| Web | https://www.bonesupport.com |
Michael Roth Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Roth against Bonesupport Holding stock is an integral part of due diligence when investing in Bonesupport Holding. Michael Roth insider activity provides valuable insight into whether Bonesupport Holding is net buyers or sellers over its current business cycle. Note, Bonesupport Holding insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bonesupport Holding'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Roth over six months ago Acquisition by Michael Roth of 1311 shares of Ryman Hospitality subject to Rule 16b-3 | ||
Michael Roth over six months ago Insider Trading |
Bonesupport Holding Management Efficiency
The company has return on total asset (ROA) of (0.1349) % which means that it has lost $0.1349 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2528) %, meaning that it generated substantial loss on money invested by shareholders. Bonesupport Holding's management efficiency ratios could be used to measure how well Bonesupport Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jeffrey Berkley | Surgical Science Sweden | 54 | |
| Oskar Bosson | BioArctic AB | 47 | |
| Rein BSc | Camurus AB | 65 | |
| Inbal MazorBadichi | Surgical Science Sweden | 54 | |
| Pr Gellerfors | BioArctic AB | 76 | |
| Annette Mattsson | Camurus AB | 57 | |
| Daniel Evestedt | Surgical Science Sweden | 46 | |
| Peter Hjelmstrom | Camurus AB | 50 | |
| Harald Borgeke | BioArctic AB | N/A | |
| Frida Lekander | BioArctic AB | N/A | |
| Katrin Gisselfalt | Xvivo Perfusion AB | 54 | |
| Ran Bronstein | Surgical Science Sweden | 59 | |
| Maria Lundqvist | Camurus AB | 57 | |
| Johanna Flting | BioArctic AB | 51 | |
| Jan Mattsson | BioArctic AB | 63 | |
| Martin Jansson | Surgical Science Sweden | 52 | |
| Pr Lannfelt | BioArctic AB | 74 | |
| Gisli Hennermark | Surgical Science Sweden | 51 | |
| Anna Ahlberg | Surgical Science Sweden | 53 | |
| Doron Zilberman | Surgical Science Sweden | 61 | |
| Andrew McLean | Camurus AB | 58 | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 |
Bonesupport Holding Leadership Team
Elected by the shareholders, the Bonesupport Holding's board of directors comprises two types of representatives: Bonesupport Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bonesupport. The board's role is to monitor Bonesupport Holding's management team and ensure that shareholders' interests are well served. Bonesupport Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bonesupport Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jerry Chang, Executive Vice President of Research & Development | ||
| AnnMarie Thor, Acting Marketing | ||
| Kristina Ingvar, Ex Affairs | ||
| Michael Roth, GM America | ||
| Prof MD, Founder Director | ||
| Fergus MacLeod, GM EUROW | ||
| Michael MD, Ex Officer | ||
| Emil Billbck, Chief Officer | ||
| Hkan Johansson, Chief Officer | ||
| Helena Brandt, Head of Human Resources |
Bonesupport Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bonesupport Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.25) % | |||
| Operating Margin | (0.27) % | |||
| Current Valuation | 5.29 B | |||
| Shares Outstanding | 64.55 M | |||
| Shares Owned By Insiders | 12.79 % | |||
| Shares Owned By Institutions | 53.83 % | |||
| Price To Book | 19.34 X | |||
| Price To Sales | 18.59 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bonesupport Stock Analysis
When running Bonesupport Holding's price analysis, check to measure Bonesupport Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonesupport Holding is operating at the current time. Most of Bonesupport Holding's value examination focuses on studying past and present price action to predict the probability of Bonesupport Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonesupport Holding's price. Additionally, you may evaluate how the addition of Bonesupport Holding to your portfolios can decrease your overall portfolio volatility.